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Spatial and temporal control of chondrogenesis generates precise, species-specific patterns of limb skeletal structures during development. Cell condensations at the core of the developing limb-bud either differentiate into transient cartilage, undergo hypertrophy, later ossifying to form the skeletal elements, or generate stable articular cartilage at joints. Computational modelling based on Turing-like reaction-diffusion mechanisms, has been used to explore pattern formation underlying limb skeletogenesis, implicating interaction between BMP and canonical-Wnt signalling as pro-and antichondrogenic factors (Raspopovic et al 2014) . In high-density micromass cultures, embryonic limb-bud cells spontaneously form a regular pattern of cartilage nodules, reflecting such a self-organising mechanism. Using this experimental scenario, in addition to showing rapid progress to hypertrophy within the population of cells, we showed that altering the signaling environment alters the nodule pattern (Saha et al 2016) . Here we develop a quantitative approach to defining the pattern of cartilage nodules in micromass cultures and examine pattern changes through spatially restricted application of BMP and Wnt signalling components, activating and blocking the pathways. Our modified micromass culture approach incorporates local release of combinations of ligands and antagonists (agarose beads or transfected cells), placed at different positions within the culture, compared to general administration (in media). We assess transient and stable cartilage differentiation through histological, immunological and in situ hybridisation imaging to reveal the spatial patterns, as well as Q-PCR profiling of chondrogenic markers. This approach to influencing chondrogenic patterns endeavours to 1) investigate complex signalling interactions across space and 2) provide an environment to create a chondrogenic pattern comparable to a joint-cartilage/rudiment interface. By controlling the molecular environment it addresses how Wnt and Bmp signalling integrate to generate spatial patterns of chondrogenesis, thus allowing greater understanding of their role in guiding stable versus transient chondrogenesis, and formation of correct skeletal structures in the correct location. Mammalian development is characterized by the formation of a blastocyst with a fluid-filled cavity segregating the cavity-facing primitive endoderm (PrE) from the epiblast (EPI) within the inner cell mass (ICM). After the first lineage segregation produces the trophectoderm and ICM, ICM cells stochastically upregulate gene expression patterns for further fate specification while fluid cavities emerge, expand and coalesce. Despite the necessity of proper blastocyst maturation through spatial segregation of fates and global morphology for later embryonic development, the mechanism underlying blastocyst self-organization has not been investigated. Here we aim to elucidate the interplay between cell fate specification (EPI-PrE sorting), apico-basal polarity and cell mechanics that are integral to the self-organization framework. By combining advanced microscopy with genetics, we are able to resolve embryo-wide dynamics of fate specification, polarity establishment and cavity expansion at a cellular level. Together with novel mechanical manipulations, this approach allows us to determine the influence of individual framework pillars and how they feed back on each other in both space and time. In skeletal muscle, lineage-specific gene expression and differentiation is regulated by cell-substrate interactions and cytoskeletal architecture. Earlier, we had reported that signaling controlled by adhesion-dependent RhoA GTPase regulates expression of the muscle determinant MyoD. In proliferating C2C12 myoblasts (MB), RhoA activation induces its effector mDiaphanous1 (mDia1, a scaffold protein), to trigger cytoskeletal reorganization and modulate MyoD expression by titrating the activity of two antagonistic pathways involving transcription factors SRF and TCF. We now report that a Rho-independent active form mDia1ΔN3, which suppresses MyoD expression in MB, does not affect the expression of MyoD in myotubes (MT). However, overexpression of mDia1ΔN3 reduced expression of Myogenin (MyoG), a major target of MyoD in MT, suggesting effects on MyoD function. To identify the distinct mechanisms by which RhoAmDia1 signaling might regulate muscle-specific transcription in MT, we identified mDia1-interacting proteins by yeast two-hybrid screening using mDia1ΔN3 as bait. Prohibitin2 (Phb2), a ubiquitously expressed pleiotropic protein, emerged as a novel partner. Using co-immuno-precipitation assays, we find that Phb2 binds mDia1 only in MT and not in MB, and that this interaction rescues the mDia1-mediated repression of MyoG expression and promoter activity. Binding of Phb2 to mDia1 in MT switches the antimyogenic function of mDia1ΔN3 to a pro-myogenic function. Moreover, Phb2 binds to a region in mDia1 identified earlier as a key determinant in repressing MyoD expression in MB, and might prevent repression of MyoD in MT. Further, Akt2, a positive regulator of skeletal muscle differentiation, and MyoD itself were co-immunoprecipitated by mDia1 in MT along with Phb2. Our findings suggest the existence of a pro-myogenic complex involving mDia1, MyoD, Akt2 and Phb2 in MT to promote MyoG expression. We propose a model where the mDia-Phb2 interaction
